期刊文献+

D-二聚体在诊断肝硬化门静脉血栓形成中的应用价值 被引量:11

The clinical value of D-dimer in cirrhotic patients with portal venous thrombosis
下载PDF
导出
摘要 目的探讨D-二聚体在肝硬化门静脉血栓形成中的预测价值。方法选我院自2005年1月至2008年12月所收肝硬化剔除不符合标准者共有83例入组,据螺旋CT增强扫描是否合并PVT分为血栓组和对照组,观测其D-二聚体水平。结果血栓组D-二聚体水平显著高于对照组。结论 D-二聚体水平异常升高可提示门静脉血栓的形成。 Objective To evaluate the level of D-dimer as a predictive indicator of portal vein thrombosis (PVT) in liver cirrhosis patients.Methods A total of 83 liver cirrhosis patients were studied prospectively. A change in the level of D-dimer was analyzed.Results The level of D-dimer in PVT patients was significantly higher than the non-PVT patients. The possibility of PVT increased with the increase in D-dimer level.Conclusion Active monitoring of D-dimer levels in patients with portal hypertension could help in early diagnosis of PVT.
作者 郭银燕
出处 《临床肝胆病杂志》 CAS 2010年第3期304-305,共2页 Journal of Clinical Hepatology
关键词 肝硬化 门静脉血栓形成 门静脉 纤维蛋白纤维蛋白原降解物 liver cirrhosis venous thrombosis portal vein fibrin fibrinogen degradation products
  • 相关文献

参考文献2

二级参考文献12

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..酒精性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):164-166. 被引量:271
  • 2Mats gren,David Bergqvist,Martin Bjrck,Stefan Acosta,Henry Eriksson,Nils H Sternby.Portal vein thrombosis:Prevalence,patient characteristics and lifetime risk:A population study based on 23796 consecutive autopsies[J].World Journal of Gastroenterology,2006,12(13):2115-2119. 被引量:68
  • 3Okuda K, Ohnishi K, Kimura K, Matsutani S, Sumida M, Goto N, Musha H, Takashi M, Suzuki N, Shinagawa T. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology 1985; 89:279-286.
  • 4Mangia A, Villani MR, Cappucci G, Santoro R, Ricciardi R, Facciorusso D, Leandro G, Caruso N, Andriulli A. Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol 2005; 17:745-751.
  • 5Romero Gomez M, Suarez Garcia E, Lopez Lacomba D, Marchante I, Grande L, Castro Fernandez M. Antiphospholipid antibodies are related to portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol 2000; 31:237-240.
  • 6Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, Iannaccone L, D'Andrea G, Marmo R, Ames PR, Balzano A. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology 2000; 31:345-348.
  • 7Erkan O, Bozdayi AM, Disibeyaz S, Oguz D, Ozcan M, Bahar K, Karayalcin S, Ozden A, Bozkaya H, Yurdaydin C, Uzunalimoglu O. Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis. Eur J Gastroenterol Hepatol 2005; 17: 339-343.
  • 8Violi F, Ferro D, Basili S, Quintarelli C, Musca A, Cordova C, Balsano F. Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis. Hepatology 1993; 17:78-83.
  • 9Romero-Gomez M, Gutierrez-Tous R, Delgado-Mije D. Anticoagulation therapy for recent portal vein thrombosis in a patient with liver cirrhosis suffering from variceal rebleeding. Gastroenterology 2002; 122: 2095.
  • 10杨镇,裘法祖.脾切除贲门周围血管离断术治疗门静脉高压症的疗效(英文)[J].中华外科杂志,2000,38(9):645-648. 被引量:79

共引文献39

同被引文献82

引证文献11

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部